# Study of Cerebrolysin for Treatment of Infants With History of Neonatal Hypoxic Ischemic Encephalopathy

> **NCT01059461** · PHASE2 · COMPLETED · sponsor: **Sahar M.A. Hassanein, MD** · enrollment: 40 (estimated)

## Conditions studied

- Hypoxic-Ischemic Encephalopathy

## Interventions

- **DRUG:** Cerebrolysin®

## Key facts

- **NCT ID:** NCT01059461
- **Lead sponsor:** Sahar M.A. Hassanein, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2013-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01059461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01059461, "Study of Cerebrolysin for Treatment of Infants With History of Neonatal Hypoxic Ischemic Encephalopathy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01059461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*